Rutgers Cancer Institute in conjunction with Robert Wood Johnson University Hospital New Brunswick, an RWJBarnabas Health facility, are now offering CAR T-cell therapy for forms of B-cell lymphoma. Learn more about this ‘living drug.’
With a high-risk form of leukemia, Lael McGrath needed a stem cell transplant. A team effort by Rutgers Cancer Institute, Robert Wood Johnson University Hospital and Be the Match helped connect her with a donor from Germany. Learn more about their special bond.
The New Jersey Devils supported the NHL's annual Hockey Fights Cancer initiative during their Saturday, Nov. 23 game against the Detroit Red Wings, honoring survivor Grace Eline as their Player for the Day. Read more
Investigators at Rutgers Cancer Institute of New Jersey have determined that an overabundance of a novel gene known as ADNP in an aggressive form of ovarian cancer may serve as a prognostic tool. Read more
A drastic, unexplained change in health had Ruth Hansen seeking answers. When diagnosed with a condition known as Cushing’s syndrome, she found expertise in the care of this rare tumor type at Rutgers Cancer Institute and RWJBarnabas Health.
Read more
Visit our Cervical Health Resource Center for interviews and information on risk factors, screening, and treatment of cervical cancer. Learn more
Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
732-235-CINJ (2465)
Patient Care
From doctor to nurse to social worker and others, our comprehensive team guides both patient and family through their cancer journey. Learn more
Clinical Trials
As one of the National Cancer Institute’s designated cancer centers, the Rutgers Cancer Institute of New Jersey provides access to the latest medicines through clinical trials.
Learn more
Research
Cancer research is one of the pillars of the Cancer Institute of New Jersey. Our physician-scientists engage in innovative techniques to unlock the mysteries of cancer, helping to make unique advances in the field.
Novel Cell-Based Therapy Induces Cell Death in Sensitive and Resistant Non-Hodgkin Lymphoma Models
Learn more
Analysis of Different Treatment Strategies for Non-Invasive Breast Cancer Shows Radiation Treatment Alone is Cost-Effective
Learn more
Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery
Learn more
Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. Learn more
Rutgers Cancer Institute Researchers Identify Novel Gene Associated with Prognosis in Aggressive form of Ovarian Cancer
Learn more
Likelihood of Prenatal Screening for Blood Disorders Varies Between Type of Healthcare Provider
Learn more
Addition of Post-Transplant Chemotherapy to Standard Immune Treatment Shows Increase of Allogeneic Transplant Patients in Remission
Learn more
Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
732-235-CINJ (2465)
Copyright ©2020 Rutgers, The State University of New Jersey, all rights reserved | Privacy Policy
Rutgers Cancer Institute of New Jersey is the state's only National Cancer Institute-designated Comprehensive Cancer Center
The information contained in this website is not a substitute for medical consultation. A physician should always be consulted for any health problem or medical condition.
